The present invention relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
本发明涉及新型
嘧啶衍
生物、含有这些化合物的药物组合物及其在治疗疾病(尤其是疼痛)中的用途,这些疾病是由
大麻素受体活性的增加或降低直接或间接引起的。